0001671858-18-000002.txt : 20180920
0001671858-18-000002.hdr.sgml : 20180920
20180920160920
ACCESSION NUMBER: 0001671858-18-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20180920
DATE AS OF CHANGE: 20180920
EFFECTIVENESS DATE: 20180920
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Silverback Therapeutics, Inc.
CENTRAL INDEX KEY: 0001671858
IRS NUMBER: 811489190
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-321856
FILM NUMBER: 181079544
BUSINESS ADDRESS:
STREET 1: 500 FAIRVIEW AVENUE NORTH, SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: 206-456-2900
MAIL ADDRESS:
STREET 1: 500 FAIRVIEW AVENUE NORTH, SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98109
D
1
primary_doc.xml
X0708
D
LIVE
0001671858
Silverback Therapeutics, Inc.
500 FAIRVIEW AVENUE NORTH, SUITE 600
SEATTLE
WA
WASHINGTON
98109
206-456-2900
DELAWARE
None
None
Corporation
true
2016
Peter
A.
Thompson
500 Fairview Ave N, Suite 600
Seattle
WA
WASHINGTON
98109
Executive Officer
Director
Robert
Hershberg
500 Fairview Ave N, Suite 600
Seattle
WA
WASHINGTON
98109
Director
Saqib
Islam
500 Fairview Ave N, Suite 600
Seattle
WA
WASHINGTON
98109
Director
Other Technology
Decline to Disclose
- 06b
false
2018-09-05
false
true
false
0
19999990
12499994
7499996
false
3
0
0
0
true
false
Silverback Therapeutics, Inc.
Jill Fishbein
Jill Fishbein
Secretary
2018-09-17